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Several metals have toxic actions on nerve cells and neurobehavioral functioning playing a role in the genesis 
and development of many neurodegenerative diseases. In particular manganese(II) is a well known neurotoxic 
metal as it accumulates in basal ganglia inducing Manganism, a pathology with common manifestations with 
Parkinson's disease [1]. YPK9 gene (Yeast PARK9; also known as YOR291W) encoded protein can protect 
cells from manganese poisoning [2]. In fact YPK9 is a non-essential yeast gene predicted by sequence to encode 
a transmembrane P-type transport ATPase involved in metal coordination and transportation. Mutations in the 
human homolog of YPK9, ATP13A2/PARK9, have been linked to genetic forms of early onset Parkinsonism. 
We tested the binding ability of Mn(II) and other divalent metal ions (Cu(II), Zn(II), Ni(II)) with several peptide 
sequences from YPK9 with particular focus on highly conserved sequences from yeast to human. The work was 
carried out at different pH values and ligand/metal molar ratios by means of potentiometric and spectroscopic 
techniques (multidimensional and heteronuclear NMR and UV-visible), in order to evaluate and compare the 
coordination propensity of such fragments with Mn(II) and the other metal probes selected, with the purpose of 
sheding a light on the protective properties of YPK9 in Manganese-induced Parkinsonism [3-5].  
 
Figure 1 – The connection between genetic and environmental PD causes in a graphical interpretation for the 
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